SQUAMISH, British Columbia–(BUSINESS WIRE)–“This 100 percent strike vote demonstrates that our members are deeply concerned about…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a…
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. – MRVI
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a…
TC BANCSHARES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TC Bancshares, Inc. – TCBC
NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.…
QUANTUM COMPUTING INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Quantum Computing Inc. – QUBT
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a…
Samsung Launches Galaxy Z Fold7, Galaxy Z Flip7 and Galaxy Watch8 Series Globally Starting Today
Multimodal AI-powered foldables debut alongside ultra-comfortable smartwatches that deliver instant health insights — experience the latest…
Samsung Launches Galaxy Z Fold7, Galaxy Z Flip7 and Galaxy Watch8 Series Globally Starting Today
Multimodal AI-powered foldables debut alongside ultra-comfortable smartwatches that deliver instant health insights — experience the latest…
Oasis Continues to Call for the Dismissal of Kusuri No Aoki’s President and Vice President (Stock Code: 3549 JT)
*President Hironori Aoki and Vice President Takanori Aoki made JPY 8.82 billion at the expense of…
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
– If Approved, Lenacapavir Would Be the First and Only Twice-Yearly HIV PrEP Option in the…
Luigi de Vecchi to Join Evercore’s European Advisory Practice as Firm Continues to Build in Europe
LONDON–(BUSINESS WIRE)–Evercore (NYSE: EVR) announced today that Luigi de Vecchi will be joining the firm in…